Literature DB >> 8351344

Cerebral sparganosis: MR imaging versus CT features.

W K Moon1, K H Chang, S Y Cho, M H Han, S H Cha, J G Chi, M C Han.   

Abstract

Fourteen magnetic resonance (MR) images of 11 patients with cerebral sparganosis were reviewed retrospectively and compared with 13 computed tomographic (CT) scans of 10 of the patients. All patients underwent both nonenhanced and contrast material-enhanced MR imaging. All white matter degenerations, which were slightly hypointense on T1-weighted images and were hyperintense on T2-weighted images, were seen as areas of low attenuation on CT scans. Better contrast between normal and degenerated brain tissues was seen at MR, and two lesions were seen that were missed at CT. The parasitic granuloma was isointense to brain parenchyma on images obtained with all pulse sequences. On two follow-up MR images, location or shape of the enhancing lesions changed, suggesting migration of the worm. A new finding of hyperintensity on T1-weighted images and hypointensity on T2-weighted images in subcortical areas probably due to petechial hemorrhages was demonstrated in eight patients only at MR. Small calcific foci, which were important diagnostic clues of cerebral sparganosis, were detected in four patients only at MR, while they were seen in eight patients at CT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8351344     DOI: 10.1148/radiology.188.3.8351344

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Functional changes in regulatory T cells during an experimental infection with sparganum (plerocercofid of Spirometra mansoni).

Authors:  Hyung-Ran Kim; Su-Min Lee; Jong-Wha Won; Woosung Lim; Byung-In Moon; Hyun-Jong Yang; Ju-Young Seoh
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

Review 2.  Neuroparasitic infections: cestodes, trematodes, and protozoans.

Authors:  M D Walker; J R Zunt
Journal:  Semin Neurol       Date:  2005-09       Impact factor: 3.420

3.  CT and MR characteristics of cerebral sparganosis.

Authors:  T Song; W-S Wang; B-R Zhou; W-W Mai; Z-Z Li; H-C Guo; F Zhou
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

4.  Experience of Dual Time Point Brain F-18 FDG PET/CT Imaging in Patients with Infectious Disease.

Authors:  Dae-Weung Kim; Chang Guhn Kim; Soon-Ah Park; Sang-Ah Jung
Journal:  Nucl Med Mol Imaging       Date:  2010-04-21

5.  Migration: a notable feature of cerebral sparganosis on follow-up MR imaging.

Authors:  Y-X Li; H Ramsahye; B Yin; J Zhang; D-Y Geng; C-S Zee
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

6.  The surgical removal of a live tapeworm with an interesting pathologic finding most likely representing the migration path: a case report of cerebral sparganosis.

Authors:  Peng Wang; Xueying Su; Qing Mao; Yanhui Liu
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

7.  Presumptive case of sparganosis manifesting as a hepatic mass: A case report and literature review.

Authors:  Gyeong Deok Jo; Jae Young Lee; Sung-Tae Hong; Jung Hoon Kim; Joon Koo Han
Journal:  World J Radiol       Date:  2016-10-28

8.  Seroprevalence of Sparganosis in Rural Communities of Northern Tanzania.

Authors:  Nicholas Kavana; Parthasarathy Sonaimuthu; Christopher Kasanga; Ayub Kassuku; Hesham M Al-Mekhlafi; Mun Yik Fong; Mohammad Behram Khan; Rohela Mahmud; Yee Ling Lau
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

9.  A Retrieved Sparganum of Spirometra erinaceieuropaei from a Korean Man during Mechanical Thrombectomy.

Authors:  Yang-Ha Hwang; Wonsoo Son; Yong-Won Kim; Dong-Hun Kang; Hyun-Ha Chang; Youn-Kyoung Goo; Yeonchul Hong; Dong-Il Chung
Journal:  Korean J Parasitol       Date:  2020-06-26       Impact factor: 1.341

10.  Cerebral sparganosis in children: epidemiological, clinical and MR imaging characteristics.

Authors:  Caigui Gong; Weihua Liao; Ashley Chineah; Xiaoyi Wang; Bob L Hou
Journal:  BMC Pediatr       Date:  2012-09-24       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.